Enspryng 120 mg solution for injection in pre-filled syringe

Licence status
Authorised: 24/06/2021
Active substances
Satralizumab
Dosage Form
Solution for injection in pre-filled syringe
Licence number
EU/1/21/1559/001
Licence holder
Roche Registration GmbH

Product documents

Licence information

ATC code
L04AA Selective immunosuppressants, L04AC19 Satralizumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
24/06/2021

Educational materials for patients